4Accepted Sep 9, 8:53 PM ET
RxSight (RXST) COO Ilya Goldshleger Exchanges Options, Receives New Awards
Accepted (ET)
8:53 PM
Sep 9, 2026
Filed
Sep 9, 2026
Documents
1
Size
29.3 KB
Summary
RxSight (RXST) COO Ilya Goldshleger Exchanges Options, Receives New Awards
What Happened
- Ilya Goldshleger, Chief Operating Officer of RxSight (RXST), participated in the issuer’s option exchange program on September 5, 2026. The Form 4 reports dispositions (surrender/cancellation) of options covering 485,567 shares and the grant/acquisition of new derivative awards covering 364,032 shares. The filing lists no per‑share cash amounts (N/A); the post‑exchange exercise price for the new awards is $6.375 per share.
- This is a derivative exchange (old options surrendered and new options issued), not an open‑market sale or a cash purchase. The new awards are subject to vesting and service conditions (see key details).
Key Details
- Transaction date: September 5, 2026 (Form 4 filed September 9, 2026).
- Reported activity: Dispositions to issuer (D) of 485,567 option shares; Grants/acquisitions (A) of 364,032 option shares. Per‑share price reported as N/A; post‑exchange exercise price for new options = $6.375.
- Exchange ratios noted in footnotes: examples include 1.33:1, 1.15:1 and 1.55:1 for different option blocks (i.e., varying numbers of old options exchanged for each new option).
- Vesting: New awards are generally subject to time‑based vesting and require continued service. Footnotes specify schedules such as monthly vesting (1/48th) from various Vesting Commencement Dates and cliff + monthly schedules (e.g., 25% vesting on Feb 28, 2027 with remainder by Aug 31, 2027 or 1/24th starting Feb 28, 2027). See filing footnotes for exact schedules per award.
- Shares owned after transaction: The Form 4 reports the specific derivative awards received and old options surrendered; it does not report a single total of common shares beneficially owned after the exchange in the provided summary — refer to the full Form 4 for total beneficial ownership.
- Filing timeliness: Form 4 was filed on Sept 9, 2026 for transactions dated Sept 5, 2026 (no late‑filing indication in the summary).
Context
- These are derivative transactions (option exchange program). That means Goldshleger did not sell stock on the open market; instead, he replaced older option grants with newly issued option awards at a set post‑exchange exercise price and with new vesting terms.
- Because the new awards vest over time and are subject to continued service, they do not represent immediately liquid stock and should not be read as an immediate bullish or bearish market action by the insider.